Why is Bliss GVS Pharma Ltd ?
1
Company has a low Debt to Equity ratio (avg) at 0 times
2
Poor long term growth as Net Sales has grown by an annual rate of 10.22% and Operating profit at 14.30% over the last 5 years
3
With a growth in Net Profit of 86.57%, the company declared Very Positive results in Sep 26
- The company has declared positive results for the last 3 consecutive quarters
- OPERATING CF(Y) Highest at Rs 138.72 Cr
- ROCE(HY) Highest at 18.76%
- DEBTORS TURNOVER RATIO(HY) Highest at 1.89 times
4
Stock is technically in a Mildly Bullish range
- Multiple factors for the stock are Bullish like MACD, KST and DOW
5
With ROE of 12.6, it has a Very Expensive valuation with a 5.3 Price to Book Value
- The stock is trading at a fair value compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of 297.71%, its profits have risen by 48.4% ; the PEG ratio of the company is 0.9
6
95.77% of Promoter Shares are Pledged
- In falling markets, high promoter pledged shares puts additional downward pressure on the stock prices
- The proportion of pledged holdings has increased by 95.77% over the last quarter
How much should you hold?
- Overall Portfolio exposure to Bliss GVS Pharma should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Bliss GVS Pharma for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Bliss GVS Pharma
297.71%
5.02
59.27%
Sensex
-2.0%
-0.13
14.98%
Quality key factors
Factor
Value
Sales Growth (5y)
10.22%
EBIT Growth (5y)
14.30%
EBIT to Interest (avg)
15.17
Debt to EBITDA (avg)
0.60
Net Debt to Equity (avg)
-0.10
Sales to Capital Employed (avg)
0.76
Tax Ratio
29.58%
Dividend Payout Ratio
4.10%
Pledged Shares
95.77%
Institutional Holding
14.65%
ROCE (avg)
12.86%
ROE (avg)
10.13%
Valuation Key Factors 
Factor
Value
P/E Ratio
42
Industry P/E
40
Price to Book Value
5.27
EV to EBIT
33.55
EV to EBITDA
28.23
EV to Capital Employed
5.74
EV to Sales
6.21
PEG Ratio
0.88
Dividend Yield
0.23%
ROCE (Latest)
17.11%
ROE (Latest)
12.61%
Loading Valuation Snapshot...
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bullish
Bullish
OBV
Mildly Bullish
Mildly Bullish
Technical Movement
32What is working for the Company
OPERATING CF(Y)
Highest at Rs 138.72 Cr
ROCE(HY)
Highest at 18.76%
DEBTORS TURNOVER RATIO(HY)
Highest at 1.89 times
NET SALES(Q)
Highest at Rs 313.37 cr
PBDIT(Q)
Highest at Rs 80.59 cr.
PBT LESS OI(Q)
Highest at Rs 66.80 cr.
PAT(Q)
Highest at Rs 52.25 cr.
EPS(Q)
Highest at Rs 4.91
-5What is not working for the Company
DPR(Y)
Lowest at 4.10%
CASH AND CASH EQUIVALENTS(HY)
Lowest at Rs 151.05 cr
Loading Valuation Snapshot...
Here's what is working for Bliss GVS Pharma
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 66.80 cr has Grown at 107.65%
Year on Year (YoY)MOJO Watch
Near term PBT trend is very positive
PBT less Other Income (Rs Cr)
Profit After Tax (PAT) - Quarterly
At Rs 52.25 cr has Grown at 91.7%
Year on Year (YoY)MOJO Watch
Near term PAT trend is very positive
PAT (Rs Cr)
Operating Cash Flow - Annually
Highest at Rs 138.72 Cr and Grown
each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (Rs Cr)
Net Sales - Quarterly
Highest at Rs 313.37 cr
in the last five quartersMOJO Watch
Near term sales trend is positive
Net Sales (Rs Cr)
Net Sales - Quarterly
At Rs 313.37 cr has Grown at 28.22%
Year on Year (YoY)MOJO Watch
Near term sales trend is positive
Net Sales (Rs Cr)
Operating Profit (PBDIT) - Quarterly
Highest at Rs 80.59 cr.
in the last five quartersMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (Rs Cr)
Profit Before Tax less Other Income (PBT) - Quarterly
Highest at Rs 66.80 cr.
in the last five quartersMOJO Watch
Near term PBT trend is positive
PBT less Other Income (Rs Cr)
Profit After Tax (PAT) - Quarterly
Highest at Rs 52.25 cr.
in the last five quartersMOJO Watch
Near term PAT trend is positive
PAT (Rs Cr)
Earnings per Share (EPS) - Quarterly
Highest at Rs 4.91
in the last five quartersMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (Rs)
Debtors Turnover Ratio- Half Yearly
Highest at 1.89 times
in the last five half yearly periodsMOJO Watch
Company has been able to settle its Debtors faster
Debtors Turnover Ratio
Here's what is not working for Bliss GVS Pharma
Dividend Payout Ratio (DPR) - Annually
Lowest at 4.10% and Fallen
each year in the last five yearsMOJO Watch
Company is distributing lower proportion of profits generated as dividend
DPR (%)
Cash and Cash Equivalents - Half Yearly
Lowest at Rs 151.05 cr
in the last six half yearly periodsMOJO Watch
Short Term liquidity is deteriorating
Cash and Cash Equivalents